Flagship Harbor Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,246
| Closed | -$119K | – | 1270 |
|
|
2020
Q3 | $119K | Sell |
1,246
-598
| -32% | -$57.1K | 0.02% | 604 |
|
|
2020
Q2 | $224K | Hold |
1,844
| – | – | 0.03% | 434 |
|
|
2020
Q1 | $160K | Buy |
1,844
+929
| +102% | +$80.6K | 0.03% | 439 |
|
|
2019
Q4 | $98K | Buy |
915
+165
| +22% | +$17.7K | 0.02% | 612 |
|
|
2019
Q3 | $67K | Buy |
+750
| New | +$67K | 0.01% | 692 |
|
|
2018
Q4 | – | Sell |
-76
| Closed | -$9K | – | 1989 |
|
|
2018
Q3 | $9K | Buy |
+76
| New | +$9K | ﹤0.01% | 1480 |
|